EMBERA NEUROTHERAPEUTICS
Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brain functions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder.
EMBERA NEUROTHERAPEUTICS
Industry:
Biotechnology Medical Device Therapeutics
Founded:
2005-01-01
Address:
Sudbury, Massachusetts, United States
Country:
United States
Website Url:
http://www.emberaneuro.com
Total Employee:
11+
Status:
Active
Contact:
+1 (318) 213-0198
Total Funding:
28.41 M USD
Technology used in webpage:
IPv6 Google Maps Google Maps API Cloudflare Hosting Cloudflare DNS Intermedia
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
Innovation Catalyst
Innovation Catalyst investment in Series A - Embera NeuroTherapeutics
Rose Research Center (RRC) in North Carolina
Rose Research Center (RRC) in North Carolina investment in Grant - Embera NeuroTherapeutics
Keiretsu Capital
Keiretsu Capital investment in Series B - Embera NeuroTherapeutics
National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA) investment in Grant - Embera NeuroTherapeutics
Keiretsu Capital
Keiretsu Capital investment in Venture Round - Embera NeuroTherapeutics
National Institutes of Health
National Institutes of Health investment in Grant - Embera NeuroTherapeutics
Keiretsu Capital
Keiretsu Capital investment in Grant - Embera NeuroTherapeutics
Keiretsu Capital
Keiretsu Capital investment in Venture Round - Embera NeuroTherapeutics
Keiretsu Capital
Keiretsu Capital investment in Venture Round - Embera NeuroTherapeutics
HRA Pharma
HRA Pharma investment in Series A - Embera NeuroTherapeutics
Official Site Inspections
http://www.emberaneuro.com Semrush global rank: 5.85 M Semrush visits lastest month: 1.42 K
- Host name: 104.21.25.122
- IP address: 104.21.25.122
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Embera NeuroTherapeutics" on Search Engine
Embera NeuroTherapeutics - Crunchbase Company Profile
Medical Device. Therapeutics. Headquarters Regions Greater Boston Area, East Coast, New England. Founded Date 2005. Founders Nicholas Edward Goeders. Operating …See details»
Embera NeuroTherapeutics | LinkedIn
Embera NeuroTherapeutics is a clinical stage pharmaceutical company developing novel treatments for to potentially treat a range of addictions located in the greater Boston, MA …See details»
Meet Embera NeuroTherapeutics’ CEO, Bob Linke, and Chief …
Jul 17, 2018 Embera NeuroTherapeutics, Inc. is a clinical-stage pharmaceutical company focused on treating a broad range of addictions where the major clinical challenge is a …See details»
Embera NeuroTherapeutics Company Profile: Valuation, Funding ...
Aug 1, 2016 Embera NeuroTherapeutics Overview. Update this profile. Year Founded. 2005. Status. Private. Latest Deal Type. Series A2. Latest Deal Amount. $20K. …See details»
Embera NeuroTherapeutics Announces First Subject Dosed in
Jun 30, 2021 BOSTON & SHREVEPORT, La.-- ( BUSINESS WIRE )--Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel …See details»
Embera NeuroTherapeutics - Funding, Financials, Valuation
$28.4M. in funding over 19 rounds. Their latest funding was raised on Feb 12, 2021 from a Series A round. Embera NeuroTherapeutics is funded by 11 investors. Innovation …See details»
Embera NeuroTherapeutics Announces First Subject Dosed in …
Aug 31, 2020 BOSTON & SHREVEPORT, La.-- ( BUSINESS WIRE )-- Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel …See details»
Development Advisory Board – Embera Neuro
Embera Neuro Jeffrey Ives, Ph.D. Dr. Ives is a Principal for NeuroPharma Advisors, LLC, a Boston area advisory group dedicated to assisting companies developing therapeutics …See details»
Embera NeuroTherapeutics, Inc. Initiates Phase 1 Clinical
May 28, 2015 BOSTON & SHREVEPORT, La.-- ( BUSINESS WIRE )-- Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel …See details»
Embera NeuroTherapeutics - Contacts, Employees, Board …
Embera NeuroTherapeutics is a development-stage pharmaceutical company developing treatments for smoking cessation and other addictions.See details»
RePORT 〉 RePORTER
Awardee Organization EMBERA NEUROTHERAPEUTICS, INC. Description. Abstract Text. DESCRIPTION (provided by applicant): Long Term Goal: Regulatory approval and …See details»
Embera NeuroTherapeutics | CipherBio
Embera NeuroTherapeutics is a clinical stage pharmaceutical company developing novel treatments for to potentially treat a range of addictions located in the greater Boston, MA …See details»
Series A - Embera NeuroTherapeutics - 2020-09-11 - Crunchbase
Organization Name. Embera NeuroTherapeutics. Announced Date Sep 11, 2020. Funding Type Series A. Funding Stage Early Stage Venture. Investors. Number of …See details»
Embera NeuroTherapeutics Announces Successful Completion of …
BOSTON, Mass. and SHREVEPORT, La.— January 6, 2016— Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel …See details»
Embera NeuroTherapeutics, Inc. Announces Successful
Jan 6, 2016 BOSTON & SHREVEPORT, La.-- ( BUSINESS WIRE )-- Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel …See details»
Organization | Embera NeuroTherapeutics, Inc. - CDEK
Organization Overview. First Clinical Trial. 2007 NCT00567814. First Marketed Drug. None First NDA Approval. None Last Known Activity ... Embera NeuroTherapeutics, Inc. …See details»
Series A - Embera NeuroTherapeutics - 2021-02-12 - Crunchbase
Feb 12, 2021 Overview. Organization Name. Embera NeuroTherapeutics. Announced Date Feb 12, 2021. Closed On Date May 7, 2021. Funding Type Series A. Funding …See details»
Embera NeuroTherapeutics - Tech Stack, Apps, Patents
Embera NeuroTherapeutics is a development-stage pharmaceutical company developing treatments for smoking cessation and other addictions.See details»